Research ArticleCLINICAL INVESTIGATIONS
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes
Yilong Ma, Chengke Tang, Thomas Chaly, Paul Greene, Robert Breeze, Stanley Fahn, Curt Freed, Vijay Dhawan and David Eidelberg
Journal of Nuclear Medicine January 2010, 51 (1) 7-15; DOI: https://doi.org/10.2967/jnumed.109.066811
Yilong Ma
Chengke Tang
Thomas Chaly
Paul Greene
Robert Breeze
Stanley Fahn
Curt Freed
Vijay Dhawan

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 1
January 2010
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes
Yilong Ma, Chengke Tang, Thomas Chaly, Paul Greene, Robert Breeze, Stanley Fahn, Curt Freed, Vijay Dhawan, David Eidelberg
Journal of Nuclear Medicine Jan 2010, 51 (1) 7-15; DOI: 10.2967/jnumed.109.066811
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes
Yilong Ma, Chengke Tang, Thomas Chaly, Paul Greene, Robert Breeze, Stanley Fahn, Curt Freed, Vijay Dhawan, David Eidelberg
Journal of Nuclear Medicine Jan 2010, 51 (1) 7-15; DOI: 10.2967/jnumed.109.066811
Jump to section
Related Articles
Cited By...
- The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
- Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation
- Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism